Journal:JBIC:20

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
<StructureSection load='' size='450' side='right' scene='Journal:JBIC:20/Cv/1' caption=''>
+
<StructureSection load='' size='450' side='right' scene='Journal:JBIC:20/Cv/2' caption=''>
=== The crystal structure of ''Sporosarcina pasteurii'' urease in a complex with citrate provides new hints for inhibitor design ===
=== The crystal structure of ''Sporosarcina pasteurii'' urease in a complex with citrate provides new hints for inhibitor design ===
<big>Stefano Benini, Paulina Kosikowska, Michele Cianci, Luca Mazzei, Antonio Gonzalez Vara,
<big>Stefano Benini, Paulina Kosikowska, Michele Cianci, Luca Mazzei, Antonio Gonzalez Vara,
Line 5: Line 5:
<hr/>
<hr/>
<b>Molecular Tour</b><br>
<b>Molecular Tour</b><br>
-
Urease, the enzyme that catalyses the hydrolysis of urea, is a virulence factor for a large number of ureolytic bacterial human pathogens. The increasing resistance of these pathogens to common antibiotics, as well as the need to control urease activity to improve the yield of soil nitrogen fertilisation in agricultural applications, has stimulated the development of novel classes of molecules that target urease as enzyme inhibitors. We report on the crystal structure of a complex formed between citrate and urease from Sporosarcina pasteurii, a widespread and highly ureolytic soil bacterium, with 1.50 Å resolution. The fit of the ligand to the active site involves stabilising interactions, such as a carboxylate group that binds the nickel ions at the active site and several hydrogen bonds with the surrounding residues. The citrate ligand has a significantly extended structure compared with previously reported ligands co-crystallised with urease and thus represents a unique and promising scaffold for the design of new, highly active, stable, selective inhibitors.
+
<scene name='Journal:JBIC:20/Cv/3'>Urease</scene>, the enzyme that catalyses the hydrolysis of urea, is a virulence factor for a large number of ureolytic bacterial human pathogens. The increasing resistance of these pathogens to common antibiotics, as well as the need to control urease activity to improve the yield of soil nitrogen fertilisation in agricultural applications, has stimulated the development of novel classes of molecules that target urease as enzyme inhibitors. We report on the crystal structure of a complex formed between citrate and urease from ''Sporosarcina pasteurii'', a widespread and highly ureolytic soil bacterium, with 1.50 Å resolution. The fit of the ligand to the active site involves stabilising interactions, such as a carboxylate group that binds the nickel ions at the active site and several hydrogen bonds with the surrounding residues. The citrate ligand has a significantly extended structure compared with previously reported ligands co-crystallised with urease and thus represents a unique and promising scaffold for the design of new, highly active, stable, selective inhibitors.
</StructureSection>
</StructureSection>
<references/>
<references/>
__NOEDITSECTION__
__NOEDITSECTION__

Revision as of 11:37, 3 February 2013

Drag the structure with the mouse to rotate
  1. REF

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools